Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 9,888	$ 4,788
Restricted cash	579	922
Accounts receivable, net of allowance for doubtful accounts of $1.3 million at both March 31, 2020 and December 31, 2019	22,703	26,493
Inventories	3,045	3,177
Prepaid expenses and other receivables	3,065	3,264
Other current assets	46	231
Assets held for sale	2,013	2,664
Total current assets	41,339	41,539
Property, plant and equipment, net of accumulated depreciation of $105.1 million and $98.0 million at March 31, 2020 and December 31, 2019, respectively	169,959	190,817
Operating lease assets	2,446	2,886
Equity investments	35	39
Intangibles, net	526	640
Other assets	149	178
Total assets	214,454	236,099
Liabilities and Shareholders’ Equity
Accounts payable	6,098	5,633
Accrued and other current liabilities	11,908	10,064
Current portion of long-term debt	19,871	6,430
Total current liabilities	37,877	22,127
Long-term debt	15,344	30,005
Noncurrent operating lease liabilities	1,387	1,457
Deferred income taxes	90	91
Long-term contingent consideration	500	500
Other long-term liabilities	7,619	7,487
Total liabilities	62,817	61,667
Commitments and contingencies
Shareholder's equity:
Preferred stock $0.01 par value (1,000 shares authorized, no shares issued and outstanding at March 31, 2020 and December 31, 2019)	0	0
Common stock, $0.01 par value (75,000 shares authorized, 15,821 shares issued and 15,761 outstanding at March 31, 2020, and 15,781 shares issued and 15,735 outstanding at December 31, 2019)	158	158
Additional paid-in capital	337,918	337,628
Treasury stock (60 shares and 46 shares at March 31, 2020 and December 31, 2019, respectively)	(477)	(436)
Accumulated deficit	(185,962)	(162,918)
Total shareholders' equity	151,637	174,432
Total liabilities and equity	$ 214,454	$ 236,099